Try our business solution for free!

Percentage return on R&D among large cap biopharma companies 2010-2020

Published by
Matej Mikulic,
Nov 7, 2022
This statistic shows the percentage of return on investment in research and development among large cap biopharmaceutical companies from 2010 to 2020. Within this time period the returns declined from 10.1 percent to 0.7 percent in 2019. 2020 saw a slight increase up to 1.7 percent.

Percentage return on investments in research and development among large cap biopharmaceutical companies from 2010 to 2020

Exclusive Premium statistic

You need a Statista Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Statista Accounts
View for free

Access to this and all other statistics on 80,000 topics from

$468 USD / Year
$828 USD / Year

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2021

Region

Worldwide

Survey time period

2010 to 2020

Special properties

12 largest biopharma companies by R&D spending

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical research and development "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Pharmaceutical research and development

Overview

6

R&D performance by company

5

Characteristics of R&D pipeline

5

Costs and ROI

4

Outsourced R&D

5

Opinions on pharma R&D

6

Further related statistics

19

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical research and development (R&D)Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu